Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Hernandez

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Mycobacteriology|November 25, 2017
Nontuberculous mycobacteria in clinical samples with negative acid-fast bacilliAlejandro Hernandez-Solís, Raúl Cicero-Sabido, Maribel González-Villa, et al.
Molecular Neurobiology|February 13, 2024
Enriched Environment Contributes to the Recovery from Neurotoxin-Induced Parkinson's Disease PathologyDaphne Alcalá-Zúniga, Erika Espinoza-Torres, Ranjit Kumar Das, et al.
The Journal of Infection|June 16, 2026
Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virusVajini N Atukorale, Jeffrey C Kwong, Alejandro Hernandez, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Adaptive Plasticity Tumor Cells Modulate MAPK-Targeting Therapy Response in Colorectal CancerOscar E Villarreal, Yixin Xu, Ha Tran, et al.
International Journal of Cancer|October 10, 2022
Is HLA type a possible cancer risk modifier in Lynch syndrome?Aysel Ahadova, Johannes Witt, Saskia Haupt, et al.
Gastroenterology|July 5, 2021
Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse ModelJohannes Gebert, Ozkan Gelincik, Mine Oezcan-Wahlbrink, et al.
Nature Communications|September 22, 2020
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolutionAlexej Ballhausen, Moritz Jakob Przybilla, Michael Jendrusch, et al.
Journal of Medical Internet Research|August 27, 2024
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCUMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2026
The TECCU-based telemonitoring platform for Inflammatory Bowel Disease is Cost-Effective: A Multicenter GETECCU TrialMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.
Therapeutic Advances in Gastroenterology|June 29, 2026
Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCUInmaculada Alonso-Abreu, Laura Ramos, Alejandro Hernandez-Camba, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Mycobacteriology|November 25, 2017
Nontuberculous mycobacteria in clinical samples with negative acid-fast bacilliAlejandro Hernandez-Solís, Raúl Cicero-Sabido, Maribel González-Villa, et al.
Molecular Neurobiology|February 13, 2024
Enriched Environment Contributes to the Recovery from Neurotoxin-Induced Parkinson's Disease PathologyDaphne Alcalá-Zúniga, Erika Espinoza-Torres, Ranjit Kumar Das, et al.
The Journal of Infection|June 16, 2026
Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virusVajini N Atukorale, Jeffrey C Kwong, Alejandro Hernandez, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Adaptive Plasticity Tumor Cells Modulate MAPK-Targeting Therapy Response in Colorectal CancerOscar E Villarreal, Yixin Xu, Ha Tran, et al.
International Journal of Cancer|October 10, 2022
Is HLA type a possible cancer risk modifier in Lynch syndrome?Aysel Ahadova, Johannes Witt, Saskia Haupt, et al.
Gastroenterology|July 5, 2021
Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse ModelJohannes Gebert, Ozkan Gelincik, Mine Oezcan-Wahlbrink, et al.
Nature Communications|September 22, 2020
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolutionAlexej Ballhausen, Moritz Jakob Przybilla, Michael Jendrusch, et al.
Journal of Medical Internet Research|August 27, 2024
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCUMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2026
The TECCU-based telemonitoring platform for Inflammatory Bowel Disease is Cost-Effective: A Multicenter GETECCU TrialMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.
Therapeutic Advances in Gastroenterology|June 29, 2026
Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCUInmaculada Alonso-Abreu, Laura Ramos, Alejandro Hernandez-Camba, et al.
Pageof 8